<DOC>
	<DOCNO>NCT01104376</DOCNO>
	<brief_summary>The purpose study see administration medicine genetic difference affect activity liver enzyme call CYP2B6 healthy volunteer .</brief_summary>
	<brief_title>Determine Effects Gene Differences Voriconazole Enzyme CYP2B6 Activity Liver Healthy Volunteers</brief_title>
	<detailed_description>The investigator test hypothesis CYP2B6 genetic variant show effect vitro also influence vivo activity CYP2B6 responsiveness metabolic inhibition , use metabolism efavirenz ( 100 mg dose ) marker activity . The metabolism pharmacokinetics efavirenz determine total 60 healthy volunteer CYP2B6*1/*1 , CYP2B6*1*6 CYP2B6*6*6 baseline ( control ) pretreatment voriconazole .</detailed_description>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>Male female subject 18 55 year age . Healthy individual without significant medical condition determine screen perform University . Adherence study dietary medication restriction . Willingness refrain smoking use tobacco marijuana one week start study completion study total 17 day . Ability commit time request study . Underweight ( weigh less 50kg 110lb ) weight [ body mass index ( BMI ) great 32 ] . Drug alcohol abuse ( 3 alcoholic drink per day regular basis ) . History intolerance allergic reaction ( e.g . rash ) efavirenz and/or voriconazole . Significant health condition heart , gastrointestinal disorder , liver , kidney disease may exacerbate course study . History current psychiatric illness ( e.g . depression , anxiety , nervousness ) . History current eye sight disturbance ( e.g . blur vision ) . Serious infection within last 2 week . Blood donation within past two month . Screening result fall healthy range . Regularly take prescription ( except hormonal agent , e.g . oral contraceptive ) , overthecounter , herbal dietary supplement , alternative medication unable unwilling stop take one week study period . Female positive pregnancy test . Female breastfeeding . Females childbearing potential unable unwilling either practice abstinence use appropriate birth control study completion , take total 17 day . Participation research study involve intensive blood sample and/or use study drug last two month . Employed student supervision investigator study . Inability state good understanding study include risk requirement , inability follow rule study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Cytochrome P450</keyword>
	<keyword>CYP2B6</keyword>
	<keyword>Voriconazole</keyword>
	<keyword>Efavirenz</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Drug-Interactions</keyword>
	<keyword>Pharmacogenetics</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>